Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

Direct-acting cannabinoid receptor agonists are well known to reduce hyperalgesic responses and allodynia after nerve injury, although their psychoactive side effects have damped enthusiasm for their therapeutic development. Alternatively, inhibiting fatty acid amide hydrolase (FAAH) and monoacylgly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kinsey, S. G., Long, J. Z., O'Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., Lichtman, A. H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Pharmacology and Experimental Therapeutics 2009
Assuntos:
Behavioral Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729802/
https://ncbi.nlm.nih.gov/pubmed/19502530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.109.155465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados